Chalmers J - Search Results

1

Benefit of treatment based on indapamide mostly combined with perindopril on mortality and cardiovascular outcomes: a pooled analysis of four trials.

Chalmers J, Mourad JJ, Brzozowska-Villatte R, De Champvallins M, Mancia G. Chalmers J, et al. J Hypertens. 2023 Mar 1;41(3):508-515. doi: 10.1097/HJH.0000000000003368. Epub 2023 Jan 19. J Hypertens. 2023. PMID: 36633311 Free PMC article.

2

Effects of perindopril-indapamide on left ventricular diastolic function and mass in patients with type 2 diabetes: the ADVANCE Echocardiography Substudy.

ADVANCE Echocardiography Substudy Investigators; ADVANCE Collaborative Group. ADVANCE Echocardiography Substudy Investigators, et al. J Hypertens. 2011 Jul;29(7):1439-47. doi: 10.1097/HJH.0b013e3283480fe9. J Hypertens. 2011. PMID: 21610514 Clinical Trial.

3

Ambulatory blood pressure after 12 weeks of quadruple combination of quarter doses of blood pressure medication vs. standard medication.

Nolde JM, Atkins E, Marschner S, Hillis GS, Chalmers J, Billiot L, Nelson MR, Reid CM, Hay P, Burke M, Jansen S, Usherwood T, Rodgers A, Chow CK, Schlaich MP. Nolde JM, et al. Among authors: chalmers j. J Hypertens. 2024 Jun 1;42(6):1009-1018. doi: 10.1097/HJH.0000000000003683. Epub 2024 Feb 28. J Hypertens. 2024. PMID: 38501351 Clinical Trial.

4

Ongoing trials of angiotensin-converting enzyme inhibition: what they can tell us.

Chalmers JP. Chalmers JP. Am J Hypertens. 2001 Aug;14(8 Pt 2):270S-275S. doi: 10.1016/s0895-7061(01)02153-7. Am J Hypertens. 2001. PMID: 11497208 Review.

5

Guidelines and consensus statements: their use and impact.

Chalmers J. Chalmers J. J Hum Hypertens. 1995 Jan;9(1):37-40. J Hum Hypertens. 1995. PMID: 7730999 No abstract available.

6

Presidential symposium on hypertension and stroke. Introduction.

Chalmers JP. Chalmers JP. J Hypertens Suppl. 1994 Dec;12(10):S3-4. J Hypertens Suppl. 1994. PMID: 7769489 No abstract available.

7

Current issues with dual inhibition of the renin-angiotensin system.

Chalmers J. Chalmers J. J Hypertens. 2013 Feb;31(2):261-2. doi: 10.1097/HJH.0b013e32835cd355. J Hypertens. 2013. PMID: 23303352 No abstract available.

8

The ABCD of anti-hypertensive therapy?

Chalmers J. Chalmers J. J Hypertens. 2002 Apr;20(4):615-6. doi: 10.1097/00004872-200204000-00016. J Hypertens. 2002. PMID: 11910294 No abstract available.

9

Enhancing risk stratification in hypertensive subjects: how far should we go in routine screening for target organ damage?

Chalmers J; 1999 World Health Organization International - Society of Hypertension (WHO-ISH). Chalmers J, et al. J Hypertens. 2002 Jul;20(7):1255-7. doi: 10.1097/00004872-200207000-00003. J Hypertens. 2002. PMID: 12131513 No abstract available.

10

All hats off to ALLHAT: a massive study with clear messages.

Chalmers J. Chalmers J. J Hypertens. 2003 Feb;21(2):225-8. doi: 10.1097/00004872-200302000-00002. J Hypertens. 2003. PMID: 12569241 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,039 results

Search Page

Filters